Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.

Autor: Gilley DR; Department of Otolaryngology-Head and Neck Surgery, University of Missouri School of Medicine, Columbia, Missouri, USA., Clark AD; Department of General Surgery, University of Missouri School of Medicine, Columbia, Missouri, USA., Wieser ME; Degree Program, University of Missouri School of Medicine, Columbia, Missouri, USA., Bollig CA; Department of Otolaryngology-Head and Neck Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Dooley LM; Department of Otolaryngology-Head and Neck Surgery, University of Missouri School of Medicine, Columbia, Missouri, USA., Biedermann GB; Department of Radiology, Division of Radiation Oncology, Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, Missouri, USA.
Jazyk: angličtina
Zdroj: Head & neck [Head Neck] 2022 Jun; Vol. 44 (6), pp. 1368-1376. Date of Electronic Publication: 2022 Mar 22.
DOI: 10.1002/hed.27035
Abstrakt: Background: Gabapentin has been shown to reduce opioid use in head and neck cancer patients. Here, we examine the efficacy of prophylactic gabapentin at reducing opioid use in these patients at our institution.
Methods: A retrospective study of patients receiving radiation was performed, using patients from our previous study as controls. Risk factors for opioid use at 3 and 6 months were determined using univariate and multivariate analyses.
Results: In total, 53/185 patients were treated with gabapentin, 39.6% of which took opioids at 3 months vs. 58.3% in the non-gabapentin cohort (p = 0.021). Gabapentin was independently associated with less opioid use on multivariate analysis at 3 months (OR 0.47, 95% CI 0.24-0.9). Gastrostomy tube dependence and pretreatment opioid use were associated with chronic opioid use despite gabapentin.
Conclusions: Gabapentin is effective at expediting opioid tapering in head and neck cancer patients who are not gastrostomy tube dependent or taking opioids pretreatment.
(© 2022 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: